G. Welzel

发表

Multiformat T-cell-engaging bispecific antibodies targeting human breast cancers.

Chan Hyuk Kim, Ying Sun, P. Schultz, 2015, Angewandte Chemie.

Engineering a long-acting, potent GLP-1 analog for microstructure-based transdermal delivery

P. Schultz, Parminder Singh, Pengyu Yang, 2016, Proceedings of the National Academy of Sciences.

Discovery of trifluoromethyl(pyrimidin-2-yl)azetidine-2-carboxamides as potent, orally bioavailable TGR5 (GPBAR1) agonists: structure-activity relationships, lead optimization, and chronic in vivo efficacy.

P. McNamara, Chun Xing Li, Yang Yang, 2014, Journal of medicinal chemistry.

Hepatobiliary and Cardiovascular Effects Limit

P. McNamara, J. Markovits, S. Chandra, 2017 .

Cardiovascular and metabolic effects of adenosine A1-receptor agonists in streptozotocin-treated rats.

K. Clark, D. Colussi, B. Cox, 1997, Journal of cardiovascular pharmacology.

The Dual Peroxisome Proliferator-Activated Receptor (cid:1) / (cid:2) Activator Muraglitazar Prevents the Natural Progression of Diabetes in db/db Mice

Simeon I. Taylor, E. Janovitz, E. Tozzo, 2007 .

An antibody CDR3-erythropoietin fusion protein.

P. Schultz, Feng Wang, Yong Zhang, 2013, ACS chemical biology.

Dissociated sterol‐based liver X receptor agonists as therapeutics for chronic inflammatory diseases

Matthew S. Tremblay, C. Glass, A. Chatterjee, 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

R. Parker, L. Hamann, M. Kirby, 2005, Journal of medicinal chemistry.

Water-in-Oil Microemulsions Containing Medium-chain Fatty Acids/Salts: Formulation and Intestinal Absorption Enhancement Evaluation

Harma Ellens, P. Constantinides, H. Ellens, 1996, Pharmaceutical Research.

Rational design of a humanized glucagon-like peptide-1 receptor agonist antibody.

P. Schultz, Feng Wang, Yong Zhang, 2015, Angewandte Chemie.

Enhanced Proteolytic Clearance of Plasma Aβ by Peripherally Administered Neprilysin Does Not Result in Reduced Levels of Brain Aβ in Mice

Jennifer L. Harris, J. Walker, E. C. Peters, 2013, The Journal of Neuroscience.

The Dual Peroxisome Proliferator-Activated Receptor α/γ Activator Muraglitazar Prevents the Natural Progression of Diabetes in db/db Mice

Simeon I. Taylor, E. Janovitz, E. Tozzo, 2007, Journal of Pharmacology and Experimental Therapeutics.

The dual peroxisome proliferator-activated receptor alpha/gamma activator muraglitazar prevents the natural progression of diabetes in db/db mice.

Simeon I. Taylor, E. Janovitz, E. Tozzo, 2007, The Journal of pharmacology and experimental therapeutics.

Discovery of highly potent, lung-localized epithelial sodium channel inhibitors.

M. Kumar, A. Chatterjee, G. Welzel, 2015, Bioorganic & medicinal chemistry letters.